PADAMOLOGY LIBRARY
Published Research
Practical insights on medical monitoring, patient safety, trial execution, and the decisions that shape early oncology development.
Precision Medicine in Hematology-Oncology: Effectively Tailoring Treatments Based on Genetic & Molecular Profiling
A practical guide to precision medicine in hematology and oncology, exploring how genetic and molecular profiling can inform more personalized treatment approaches.
Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations
A discussion of the medical, operational, and practical considerations involved in expanding CAR T-cell therapy beyond oncology.
Preparing CRAs for Success in Oncology: Targeted Training in an Era of Advanced Therapeutics
An examination of how specialized training can prepare clinical research associates to navigate the increasing complexity of oncology trials and advanced therapeutics.
Accelerating the New Wave of CAR T Therapy Trials
An industry discussion exploring the evolving CAR T-cell therapy landscape and the challenges of advancing clinical trials for emerging treatments.
The Role of Oncology Biomarkers in Personalizing Hematology Treatment Plans
An exploration of the role biomarkers play in supporting personalized treatment strategies and informing clinical decision-making in hematology and oncology.
Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
A Phase I/II study evaluating palbociclib, pembrolizumab, and letrozole in hormone receptor-positive metastatic breast cancer.
Characteristics Associated with Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults
A systematic review examining factors associated with changes in functional status among older adults receiving systemic cancer treatment.
Phase II Study of Neratinib in Older Adults with HER2 Amplified or HER2/3 Metastatic Breast Cancer
A Phase II study of neratinib in older adults with HER2-amplified or HER2/3-mutated metastatic breast cancer.
Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer
A Phase II trial evaluating pembrolizumab and enobosarm in androgen receptor-positive metastatic triple-negative breast cancer.
Older Adult Participation in Cancer Clinical Trials: A Systematic Review of Barriers and Interventions
A systematic review of barriers to older adult participation in cancer clinical trials and interventions designed to improve enrollment.
Patient Factors Associated with Changes in Functional Status During Systemic Cancer Therapy in Older Adults: A Systematic Review
A systematic review examining patient factors associated with changes in functional status during systemic cancer therapy in older adults.
Tolerability of Neratinib in Older Adults with HER2 Positive or HER2 Mutated Metastatic Breast Cancer
A published abstract examining the tolerability of neratinib in older adults with HER2-positive or HER2-mutated metastatic breast cancer.
Strategies to Improve Participation of Older Adults in Cancer Research
Strategies for improving the participation and representation of older adults in cancer research.
Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists
Research examining community oncologists’ perceptions of barriers to participation in therapeutic clinical trials.
Gut Microbiome Profiling of Patients with Metastatic Breast Cancer Undergoing Immune Checkpoint Inhibitor Therapy
Research exploring gut microbiome profiles among patients with metastatic breast cancer receiving immune checkpoint inhibitor therapy.
A Phase II Study of Pembrolizumab, Letrozole, and Palbociclib in Patients with Metastatic Estrogen Receptor-Positive Breast Cancer
A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.
Barriers to Clinical Trial Enrollment of Older Adults with Cancer: A Qualitative Study of the Perceptions of Community and Academic Oncologists
A Phase II study investigating pembrolizumab, letrozole, and palbociclib in patients with metastatic estrogen receptor-positive breast cancer.